Johnson Fistel, LLP Files Class Action Suit Against GoodRx (GDRX)
News provided by
Share this article
Share this article
SAN DIEGO, Dec. 20, 2020 /PRNewswire/ Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of shareholders of GoodRx Holdings, Inc. (NASDAQ: GDRX) Class A common stock. The class action is on behalf of shareholders who purchased GoodRx between September 23, 2020 and November 16, 2020, both dates inclusive (the Class Period ). If you wish to serve as lead plaintiff in this class action, you must move the Court no later than
February 16, 2021.
The GoodRx class action lawsuit charges GoodRx and certain of its officers and directors with violations of the Securities Exchange Act of 1934. GoodRx provides consumers with free information and tools that allow them to compare prices and save on their prescription drug purchases. The Company provides its users with these services via apps and websites that display prices and discount